Connective tissue nevus misdiagnosed as juvenile localized scleroderma.

Pediatr Rheumatol Online J

Rheumatology Unit, Department of Woman and Child Health, University Hospital of Padova, Via Giustiniani 3, Padova, 35128, Italy.

Published: October 2023

AI Article Synopsis

  • Connective tissue nevi (CTN) are benign skin growths that can resemble juvenile localized scleroderma (JLS), leading to misdiagnosis and unnecessary treatment in pediatric patients.* -
  • A study examined 17 children initially diagnosed with JLS, finding that all had CTN, with symptoms mainly localized on the limbs and no significant inflammatory markers present.* -
  • The research highlights the importance of distinguishing between CTN and JLS to avoid aggressive immunosuppressive treatments that are inappropriate for CTN patients.*

Article Abstract

Background: Connective tissue nevi (CTN) are congenital hamartomas caused by excessive proliferation of dermis components. In children, CTN can mimic juvenile localized scleroderma (JLS), an immune mediated skin disorder that requires aggressive immunosuppression.

Objectives: Aim of our study was to describe a series of pediatric patients with CTN misdiagnosed as JLS and the discerning characteristics between the two conditions.

Methods: Retrospective analysis of children referred to our Center during the last two decades for JLS who received a final diagnosis of CTN. Clinical, laboratory, histopathological and instrumental data (MRI and thermography) were collected and compared with those with JLS.

Results: Seventeen patients with mean age at onset 4.6 years entered the study. All came to our Center with a certain diagnosis of JLS (n = 15) or suspected JLS (n = 2). The indurated skin lesions were flat and resembled either circumscribed morphea or pansclerotic morphea. In 14 patients (82.4%) they were mainly localized at the lower limbs and in three (17.6%) at the upper limbs. No patient had laboratory inflammatory changes or positive autoantibodies. Skin biopsies confirmed the diagnosis of CTN: non-familial collagenoma in eleven (64.7%), mixed CTN in four (23.5%) and familial CTN in two (11.8%). Mean age at final diagnosis was 9.5 years, with a mean diagnostic delay of 4.8 years (range 1-15 years). Sixteen patients underwent musculoskeletal MRI that was normal in all except two who showed muscle perifascial enhancement. Thermography was normal in all patients. At our first evaluation, eleven patients (64.7%) were on systemic treatment (methotrexate 11, corticosteroids 7, biologics 2), three (17.6%) on topical corticosteroids and three untreated.

Conclusions: CTN can be misdiagnosed as JLS and therefore aggressively treated with prolonged and inappropriate immunosuppression. The absence of inflammatory appearance of the skin lesions, normal instrumental and laboratory findings and the accurate evaluation of skin biopsy are crucial to address the right diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583392PMC
http://dx.doi.org/10.1186/s12969-023-00913-9DOI Listing

Publication Analysis

Top Keywords

connective tissue
8
juvenile localized
8
localized scleroderma
8
ctn
8
ctn misdiagnosed
8
misdiagnosed jls
8
final diagnosis
8
diagnosis ctn
8
skin lesions
8
three 176%
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!